284 studies found for:    autism spectrum disorders OR autism OR pervasive developmental disorders OR PDD OR Kanner's syndrome OR child mental disorders OR asperger syndrome OR autistic OR developmental disabilities | Open Studies | Exclude Unknown | NIH
Show Display Options
Rank Status Study
21 Recruiting A Salivary miRNA Diagnostic Test for Autism
Conditions: Autism Spectrum Disorder;   Developmental Delay
Interventions: Other: Salivary collection;   Other: Vineland Adaptive Behavior Scale-II Assessment;   Other: Medical history questionaire;   Other: Autism Diagnostic Observation Schedule -2nd edition (ADOS-2)
22 Recruiting Children's Autism Metabolome Project
Conditions: Autism Spectrum Disorder;   Developmental Disorder
Intervention:
23 Recruiting Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
Conditions: Autistic Disorder;   Autism Spectrum Disorder;   Asperger's Syndrome;   Pervasive Developmental Disorder
Interventions: Behavioral: Cognitive Enhancement Therapy;   Behavioral: Enriched Supportive Therapy
24 Recruiting Changing Developmental Trajectories Through Early Treatment
Condition: Autism Spectrum Disorders
Interventions: Behavioral: PII with IES;   Behavioral: IES
25 Recruiting Pivotal Response Treatment Package for Young Children With Autism
Conditions: Autism Spectrum Disorder (ASD);   Autism
Intervention: Behavioral: Pivotal Response Treatment Package (PRT-P)
26 Recruiting Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
Condition: Autism
Interventions: Drug: Risperidone;   Drug: Placebo
27 Recruiting Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors
Condition: Autism Spectrum Disorders
Interventions: Drug: Placebo Nasal Spray;   Drug: Oxytocin Nasal Spray
28 Recruiting Road to Discovery for Combination Probiotic BB-12 With LGG in Treating Autism Spectrum Disorder
Conditions: Autism;   Inflammation
Interventions: Drug: BB-12 with LGG;   Drug: Placebo
29 Not yet recruiting Collaborative Study Of Neurofeedback Training Of 6-18 Year Olds With Autism
Condition: Autism
Intervention: Behavioral: Neurofeedback training
30 Recruiting Brain Imaging of Intranasal Oxytocin Treatment in Autism
Condition: Autism Spectrum Disorders
Intervention: Drug: Oxytocin
31 Recruiting The Role of Vasopressin in the Social Deficits of Autism
Condition: Autism Spectrum Disorders
Interventions: Drug: Vasopressin;   Drug: Placebo
32 Recruiting Schema, Emotion, and Behavior Therapy for Children
Condition: Autism Spectrum Disorder
Interventions: Behavioral: Individual Cognitive Behavioral Therapy;   Behavioral: Standard Community Treatment
33 Recruiting Gaming for Autism to Mold Executive Skills Project
Condition: Autism Spectrum Disorders
Intervention: Behavioral: Computerized executive control training
34 Recruiting Parent Language Intervention for Autism
Condition: Autism
Interventions: Behavioral: Responsive Intervention;   Behavioral: Directive Intervention
35 Recruiting Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Condition: Tuberous Sclerosis Complex
Intervention:
36 Recruiting Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer
Conditions: Metastatic Malignant Neoplasm in the Brain;   Stage IIIA Large Cell Lung Carcinoma;   Stage IIIA Lung Adenocarcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Large Cell Lung Carcinoma;   Stage IIIB Lung Adenocarcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Large Cell Lung Carcinoma;   Stage IV Lung Adenocarcinoma;   Stage IV Non-Small Cell Lung Cancer
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Cisplatin;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Methoxyamine;   Drug: Pemetrexed Disodium
37 Recruiting Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors
Condition: Neoplasms
Intervention: Drug: Veliparib + VX-970 + Cisplatin
38 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
39 Recruiting WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Drug: Docetaxel;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Procedure: Therapeutic Conventional Surgery;   Drug: WEE1 Inhibitor AZD1775
40 Recruiting Cisplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
Conditions: Colorectal Large Cell Neuroendocrine Carcinoma;   Esophageal Large Cell Neuroendocrine Carcinoma;   Gallbladder Large Cell Neuroendocrine Carcinoma;   Gastric Large Cell Neuroendocrine Carcinoma;   Pancreatic Large Cell Neuroendocrine Carcinoma;   Small Intestinal Large Cell Neuroendocrine Carcinoma
Interventions: Drug: Capecitabine;   Drug: Cisplatin;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Temozolomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years